Attitudes toward psychiatric drug treatment: the experience of being treated.
BACKGROUND
Effectiveness and tolerability of psychiatric medications are not only determined by the drug's pharmacological profile but through the interaction of different factors, including patients' attitudes toward their prescribed medications. Increased knowledge about those attitudes may help prescribers to improve patient concordance and thereby the effectiveness of the pharmacological therapy.


OBJECTIVE
The goal of this study was to assess stable psychiatric outpatients' attitudes toward psychiatric drug treatment and to what extent patients and public opinions on this subject diverge as a consequence of being on this type of medication.


METHODS
Two anonymous self-reported questionnaires [Drug Attitude Inventory (DAI)-10 and an abridge version of Beliefs about Medicines Questionnaire (BMQ)] were administered to 270 stable psychiatric outpatients under treatment and 292 citizens naïve to psychotropic medication.


RESULTS
Psychiatric patients showed a more positive attitude toward medication (DAI score 3.6 vs. -0.7; range -10 to +10; negative to positive). Up to 77% of patients showed positive scores compared with only 36% in the general population. Multiple regression analysis showed that none of the variables in the analysis have a predictive value with regard to the attitude toward psychiatric drugs used.


CONCLUSIONS
The continuous use of psychotropic medication shapes the opinion of the users toward a more beneficial perception of medications, but the opinion on the general population, where stigmatizing attitudes are born, is more negative toward them. For psychiatrists and their patients, trying to achieve a better understanding of each other's expectations and reaching concordance is mandatory.
De Las Cuevas
Carlos
C
Department of Psychiatry, School of Medicine, University of La Laguna, Campus de Ofra, Carretera La Cuesta-Taco s/n., 38071, La Laguna Tenerife, Canary Islands, Spain. cdelascuevas@gmail.com
Sanz
Emilio J
EJ
D000328:Adult; D000368:Aged; D001294:Attitude to Health; D003625:Data Collection; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010045:Outpatients / Q000523:psychology*; D011569:Psychiatric Status Rating Scales; D011594:Psychometrics / Q000379:methods; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012044:Regression Analysis; D012650:Self Disclosure; D013240:Stereotyping
D011619:Psychotropic Drugs
BMJ. 2003 Oct 11;327(7419):858-60
14551105
Soc Psychiatry Psychiatr Epidemiol. 2005 Nov;40(11):855-64
16215879
Pharmacopsychiatry. 1993 Jul;26(4):114-20
8234450
Psychiatr Serv. 2002 Oct;53(10):1319-21
12364685
Acta Psychiatr Scand. 2006 Mar;113(3):161-2
16466401
J Nerv Ment Dis. 1997 Mar;185(3):151-8
9091596
Br J Psychiatry. 1979 Aug;135:115-21
497614
Psychiatr Serv. 2002 Sep;53(9):1180-1
12221324
Psychol Med. 1983 Feb;13(1):177-83
6133297
BMJ. 1999 Sep 18;319(7212):787
10488029
Acta Psychiatr Scand. 2005 Jan;111(1):68-73
15636596
Br J Psychiatry. 1997 Sep;171:233-7
9337975
J Clin Psychiatry. 2004 Oct;65(10):1372-6
15491241
Psychol Med. 1992 May;22(2):347-52
1615101